VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria
- PMID: 33633743
- PMCID: PMC7900151
- DOI: 10.3389/fimmu.2020.624126
VAR2CSA-Mediated Host Defense Evasion of Plasmodium falciparum Infected Erythrocytes in Placental Malaria
Abstract
Over 30 million women living in P. falciparum endemic areas are at risk of developing malaria during pregnancy every year. Placental malaria is characterized by massive accumulation of infected erythrocytes in the intervillous space of the placenta, accompanied by infiltration of immune cells, particularly monocytes. The consequent local inflammation and the obstruction of the maternofetal exchanges can lead to severe clinical outcomes for both mother and child. Even if protection against the disease can gradually be acquired following successive pregnancies, the malaria parasite has developed a large panel of evasion mechanisms to escape from host defense mechanisms and manipulate the immune system to its advantage. Infected erythrocytes isolated from placentas of women suffering from placental malaria present a unique phenotype and express the pregnancy-specific variant VAR2CSA of the Plasmodium falciparum Erythrocyte Membrane Protein (PfEMP1) family at their surface. The polymorphic VAR2CSA protein is able to mediate the interaction of infected erythrocytes with a variety of host cells including placental syncytiotrophoblasts and leukocytes but also with components of the immune system such as non-specific IgM. This review summarizes the described VAR2CSA-mediated host defense evasion mechanisms employed by the parasite during placental malaria to ensure its survival and persistence.
Keywords: PfEMP1; Plasmodium falciparum; VAR2CSA; VAR2CSA polymorphism; immune evasion; immuno-modulation; placental malaria.
Copyright © 2021 Tomlinson, Semblat, Gamain and Chêne.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest
Figures


Similar articles
-
Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12485-90. doi: 10.1073/pnas.1103708108. Epub 2011 Jul 11. Proc Natl Acad Sci U S A. 2011. PMID: 21746929 Free PMC article.
-
Progress and Insights Toward an Effective Placental Malaria Vaccine.Front Immunol. 2021 Feb 25;12:634508. doi: 10.3389/fimmu.2021.634508. eCollection 2021. Front Immunol. 2021. PMID: 33717176 Free PMC article. Review.
-
Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin.Exp Parasitol. 2007 Sep;117(1):1-8. doi: 10.1016/j.exppara.2007.03.002. Epub 2007 Mar 14. Exp Parasitol. 2007. PMID: 17442305
-
VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.Sci Rep. 2019 Nov 18;9(1):16978. doi: 10.1038/s41598-019-53334-8. Sci Rep. 2019. PMID: 31740695 Free PMC article.
-
Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway.Braz J Med Biol Res. 2006 Dec;39(12):1525-36. doi: 10.1590/s0100-879x2006001200003. Braz J Med Biol Res. 2006. PMID: 17160261 Review.
Cited by
-
Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity.Commun Biol. 2021 Nov 19;4(1):1309. doi: 10.1038/s42003-021-02787-7. Commun Biol. 2021. PMID: 34799664 Free PMC article.
-
Malaria diagnosis challenges and pfhrp2 and pfhrp3 gene deletions using pregnant women as sentinel population in Nanoro region, Burkina Faso.Pathog Glob Health. 2024 Sep;118(6):481-491. doi: 10.1080/20477724.2024.2388489. Epub 2024 Aug 14. Pathog Glob Health. 2024. PMID: 39140699 Free PMC article.
-
Multi-System Dysregulation in Placental Malaria Contributes to Adverse Perinatal Outcomes in Mice.bioRxiv [Preprint]. 2025 Jan 15:2025.01.15.633265. doi: 10.1101/2025.01.15.633265. bioRxiv. 2025. Update in: Infect Immun. 2025 Jul 8;93(7):e0002125. doi: 10.1128/iai.00021-25. PMID: 39868257 Free PMC article. Updated. Preprint.
-
Potential pharmacologic interventions targeting TLR signaling in placental malaria.Trends Parasitol. 2022 Jul;38(7):513-524. doi: 10.1016/j.pt.2022.04.002. Epub 2022 May 7. Trends Parasitol. 2022. PMID: 35537977 Free PMC article. Review.
-
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum.Biomolecules. 2024 Jan 12;14(1):100. doi: 10.3390/biom14010100. Biomolecules. 2024. PMID: 38254700 Free PMC article. Review.
References
-
- World Health Organization World Malaria Report 2019. Geneva: World Health Organization; (2019) Licence: CC BY-NC-SA 3.0 IGO.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources